What does this research mean for the field?

Nanoparticle-based drug delivery systems enhance therapeutic performance through tunable physicochemical properties, but their successful clinical translation requires overcoming significant manufacturing, biological, and regulatory barriers. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the design principles, mechanistic behaviors, and clinical applications of nanoparticle drug delivery systems while outlining critical translational barriers.

September 8, 2026MoleculesOpen Access

Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation

View Full Paper

Ask AI

Bookmark

Authors

SJSubin Antony JoseUniversity of Nevada, Reno BCBenjamin Crutchfield MCMario Caballero

Discussion

Member takes

Overview

Narrative review demonstrates advances in nanoparticle drug delivery platforms across clinical disease models, highlighting engineering and regulatory hurdles to translation.

Key Points

To evaluate the design principles, mechanistic behaviors, and clinical applications of nanoparticle drug delivery systems while outlining critical translational barriers.
Reviewed major nanoparticle platforms, encompassing lipid, polymeric, inorganic, carbon-based, and hybrid architectures.
Evaluated targeting modalities and stimulus-responsive release mechanisms across oncology, infectious diseases, gene therapy, and neurology.
Analyzed the integration of artificial intelligence and computational modeling alongside regulatory and manufacturing hurdles.
Nanoparticle physicochemical properties dictate cellular uptake, pharmacokinetics, and clearance, though therapeutic performance faces limitations from biological heterogeneity and EPR effect variability.
Computational modeling, artificial intelligence, and digital twins improve formulation design and support tailored precision nanomedicine regimens.
Widespread clinical implementation requires resolving significant bottlenecks in manufacturing scale-up, long-term safety evaluation, and standardized regulatory frameworks.

Cite This Study

Jose et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd7c658e84d0ff5b46c7e https://doi.org/10.3390/molecules31173121

View Full Paper

Ask AI

Bookmark

September 8, 2026MoleculesOpen Access

Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation

View Full Paper

Ask AI

Bookmark

Authors

SJSubin Antony JoseUniversity of Nevada, Reno BCBenjamin Crutchfield MCMario Caballero

Discussion

Member takes

Overview

Narrative review demonstrates advances in nanoparticle drug delivery platforms across clinical disease models, highlighting engineering and regulatory hurdles to translation.

Key Points

To evaluate the design principles, mechanistic behaviors, and clinical applications of nanoparticle drug delivery systems while outlining critical translational barriers.
Reviewed major nanoparticle platforms, encompassing lipid, polymeric, inorganic, carbon-based, and hybrid architectures.
Evaluated targeting modalities and stimulus-responsive release mechanisms across oncology, infectious diseases, gene therapy, and neurology.
Analyzed the integration of artificial intelligence and computational modeling alongside regulatory and manufacturing hurdles.
Nanoparticle physicochemical properties dictate cellular uptake, pharmacokinetics, and clearance, though therapeutic performance faces limitations from biological heterogeneity and EPR effect variability.
Computational modeling, artificial intelligence, and digital twins improve formulation design and support tailored precision nanomedicine regimens.
Widespread clinical implementation requires resolving significant bottlenecks in manufacturing scale-up, long-term safety evaluation, and standardized regulatory frameworks.

Cite This Study

Jose et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd7c658e84d0ff5b46c7e https://doi.org/10.3390/molecules31173121

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark